{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:13:56Z","timestamp":1793236436327,"version":"4.5.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0137252","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T21:23:03Z","timestamp":1444252983000},"page":"e0137252","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy and Safety of Metronidazole Monotherapy versus Vancomycin Monotherapy or Combination Therapy in Patients with Clostridium difficile Infection: A Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"10","author":[{"given":"Rui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laichun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,7]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tim.2014.04.003","article-title":"Clostridium difficile spore biology: sporulation, germination, and spore structural proteins","volume":"22","author":"SD Paredes","year":"2014","journal-title":"Trends Microbiol"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1586\/eri.12.135","article-title":"Epidemiology, diagnosis and treatment of Clostridium difficile infection","volume":"10","author":"B Matteo","year":"2012","journal-title":"Expert Rev Anti Infect ther"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"SH Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1469-0691.2009.03099.x","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)","volume":"15","author":"MP Bauer","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1128\/AAC.00090-08","article-title":"Both Oral Metronidazole and Oral Vancomycin Promote Persistent Overgrowth of Vancomycin-Resistant Enterococci during Treatment of Clostridium difficile-Associated Disease","volume":"52","author":"NA Wafa","year":"2008","journal-title":"Antimicrob Agents Ch"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2146\/ajhp110371","article-title":"Fidaxomicin: A novel macrocyclic antibiotic for the treatment of Clostridium difficile infection","volume":"69","author":"C Tonya","year":"2012","journal-title":"Am J Health-Syst Pharm"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial","volume":"12","author":"OA Cornely","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MCG.0b013e31814a4e97","article-title":"Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea:an uncontrolled pilot study","volume":"43","author":"KW Garey","year":"2009","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.anaerobe.2009.08.004","article-title":"Rifaximin redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment","volume":"15","author":"S Johnson","year":"2009","journal-title":"Anaerobe"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/506354","article-title":"Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of clostridium difficile-associated diarrhea","volume":"43","author":"L Danny","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/506351","article-title":"Nitazoxanide for the treatment of Clostridium difficile colitis","volume":"43","author":"DM Musher","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1086\/596552","article-title":"Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study","volume":"48","author":"DM Musher","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/cid\/ciu313","article-title":"Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials","volume":"59","author":"J Stuart","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1086\/599224","article-title":"Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection","volume":"48","author":"BL Herpers","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal Infusion of Donor Feces for recurrent Clostridium difficile","volume":"368","author":"NE Van","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/0897190013499525","article-title":"The Role of Vancomycin and Metronidazole for the Treatment of Clostridium difficile\u2013Associated Diarrhea","volume":"26","author":"BT Serina","year":"2013","journal-title":"J Pharm Pract"},{"key":"ref17","unstructured":"Louie T, Gerdsom M, Grimard D. Results of a phase III trial comparing tolevamer, vancomycin, and metronidazole in patients with Clostridium difficile associated diarrhea (CDI). Abstract presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 17\u201320 September 2007."},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00005650-198301000-00002","article-title":"Measuring severity of illness: homogeneous case mix groups","volume":"21","author":"SD Horn","year":"1983","journal-title":"Med Care"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"62","author":"A Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/PHAR.1002","article-title":"A Real-World Evaluation of Oral Vancomycin for Severe Clostridium difficile Infection: Implications for Antibiotic Stewardship Programs","volume":"32","author":"L Frank","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized Clinical trials: is blinding necessary","volume":"17","author":"AR Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"ref22","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"JP Higgins","year":"2011"},{"issue":"7109","key":"ref23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"Brit Med J"},{"issue":"7304","key":"ref24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"JA Sterne","year":"2001","journal-title":"Brit Med J"},{"issue":"5","key":"ref25","first-page":"1","article-title":"Inclusion of zero total event trials in meta-analysesmaintains analytic consistency and incorporates all available data","volume":"7","author":"OF Jan","year":"2007","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"FA Zar","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/588293","article-title":"Comparison of clinical and microbiological response to treatment of Clostridium difficile\u2013associated disease with metronidazole and vancomycin","volume":"47","author":"NA Wafa","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/501126","article-title":"Management and Outcomes of a First Recurrence of Clostridium difficile\u2013Associated Disease in Quebec, Canada","volume":"42","author":"P Jacques","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00277-009-0772-0","article-title":"Clostridium difficile associated diarrhoea, a frequent complication in patients with acute myeloid leukaemia","volume":"89","author":"S Enrico","year":"2010","journal-title":"Ann Hematol"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/clinids\/22.5.813","article-title":"Comparison ofVancomycin, Teicoplanin, Metronidazole, and Fusidic Acid for the Treatment of Clostridium difficile-Associated Diarrhea","volume":"22","author":"C Wenisch","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MPG.0b013e3181f97209","article-title":"Clostridium difficile Infection and Treatment in the Pediatric Inflammatory Bowel Disease Population","volume":"52","author":"M Ethan","year":"2011","journal-title":"J Pediatr Gastr Nutr"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/cid\/cit075","article-title":"The Epidemiology of Clostridium difficile Infection in Children: A Population-Based Study","volume":"56","author":"K Sahil","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jhin.2012.12.019","article-title":"Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection","volume":"85","author":"SN Bass","year":"2013","journal-title":"J Hosp Infect"},{"issue":"4","key":"ref34","first-page":"397","article-title":"Predictors of First Recurrence in Clostridium diffcile-Associated Disease. A Study of 306 Patients Hospitalized in a Romanian Tertiary Referral Center","volume":"22","author":"L Mihaela","year":"2013","journal-title":"J Gastrointestin Liver Dis"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/1078155213490004","article-title":"A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies","volume":"20","author":"RP Sapna","year":"2014","journal-title":"J Oncol Pharm Pract"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(83)91036-X","article-title":"Prospective randomised trial of metronidazole versus vancomycin for Clostridium difficile\u2013associated diarrhea and colitis","volume":"2","author":"DG Teasley","year":"1983","journal-title":"Lancet"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1155\/2005\/326296","article-title":"Clostridium difficile\u2013associated diarrhea in 200 Canadian children","volume":"19","author":"V Morinville","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/00365548.2011.631029","article-title":"Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1\/BI\/027 setting","volume":"44","author":"AV Anilrudh","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jhin.2013.04.017","article-title":"Assessment of treatment patterns and patient outcomes before vs after implementation of a severitybased Clostridium difficile infection treatment policy","volume":"85","author":"CG Jardin","year":"2013","journal-title":"J Hosp Infect"},{"key":"ref40","first-page":"287","article-title":"Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan","volume":"45","author":"CL Yi","year":"2012","journal-title":"J Microbiol Immunol"},{"issue":"136","key":"ref41","first-page":"1","article-title":"Vancomycin or Metronidazole for Treatment of Clostridium difficile Infection: Clinical and Economic Analyses","volume":"1","author":"P Christine","year":"2011","journal-title":"CADTH Technology Report"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0137252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T01:11:23Z","timestamp":1588986683000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0137252"}},"subtitle":[],"editor":[{"given":"Abhishek","family":"Deshpande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,7]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0137252","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,7]]}}}